Crossmark

Letter to the editor: A double-blind, randomized, placebo-controlled study to evaluate the efficacy of Oxybutynin Chloride Extended-Release tablets on the double-J stent related symptoms following uncomplicated ureteroscopic lithotripsy

Crossref DOI link: https://doi.org/10.1007/s00240-025-01747-8

Published Online: 2025-04-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Meng, Xi

Jin, Ming

Zhang, Weizhong

Lv, Daibing

Liao, Xiaoxing

Yang, Jianghua
Funding

Funding for this research was provided by:

Capital Health Research and Development of Special Fund (2024-3-7036)
License Information

Text and Data Mining valid from 2025-04-17

Version of Record valid from 2025-04-17
More Information

Article History

Received: 21 March 2025

Accepted: 5 April 2025

First Online: 17 April 2025

Declarations

:

: Not applicable.

: All authors have given their consent for the publication of this article.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below